[go: up one dir, main page]

MY139844A - 1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system - Google Patents

1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system

Info

Publication number
MY139844A
MY139844A MYPI20035008A MYPI20035008A MY139844A MY 139844 A MY139844 A MY 139844A MY PI20035008 A MYPI20035008 A MY PI20035008A MY PI20035008 A MYPI20035008 A MY PI20035008A MY 139844 A MY139844 A MY 139844A
Authority
MY
Malaysia
Prior art keywords
disorders
inhibition
prevention
treatment
nervous system
Prior art date
Application number
MYPI20035008A
Inventor
Mario Rottlander
Andreas Ritzen
Morten Bang Noergaard
Nikolay Khanzhin
Christian Wenzel Tornoee
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY139844(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MY139844A publication Critical patent/MY139844A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE PRESENT INVENTION CONCERNS 1,2,4-TRIAMINOBENZENE DERIVATIVES OF THE GENERAL FORMULA I OR PHARMACEUTICALLY ACCEPTABLE SALTS THEROF
MYPI20035008A 2002-12-27 2003-12-26 1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system MY139844A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27

Publications (1)

Publication Number Publication Date
MY139844A true MY139844A (en) 2009-11-30

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20035008A MY139844A (en) 2002-12-27 2003-12-26 1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system

Country Status (17)

Country Link
KR (1) KR20050089862A (en)
CN (1) CN100448867C (en)
AR (1) AR042656A1 (en)
BR (1) BR0317748A (en)
CL (1) CL2003002748A1 (en)
EA (1) EA008589B1 (en)
HK (1) HK1088317A1 (en)
IS (1) IS2649B (en)
MY (1) MY139844A (en)
NO (1) NO20053612L (en)
PE (1) PE20041015A1 (en)
PL (1) PL377221A1 (en)
SI (1) SI1578740T1 (en)
TW (1) TWI325414B (en)
UA (1) UA79666C2 (en)
UY (1) UY28151A1 (en)
ZA (1) ZA200504565B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (en) * 1992-01-08 1993-07-15 Asta Medica Ag NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE19539861A1 (en) * 1995-10-26 1997-04-30 Asta Medica Ag Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
CN100448867C (en) 2009-01-07
IS2649B (en) 2010-08-15
TWI325414B (en) 2010-06-01
KR20050089862A (en) 2005-09-08
NO20053612L (en) 2005-09-23
CN1732162A (en) 2006-02-08
AR042656A1 (en) 2005-06-29
PE20041015A1 (en) 2005-01-08
IS7856A (en) 2005-05-23
TW200413280A (en) 2004-08-01
EA008589B1 (en) 2007-06-29
EA200501053A1 (en) 2005-12-29
ZA200504565B (en) 2006-08-30
UA79666C2 (en) 2007-07-10
SI1578740T1 (en) 2007-08-31
BR0317748A (en) 2005-11-22
CL2003002748A1 (en) 2005-04-08
NO20053612D0 (en) 2005-07-25
PL377221A1 (en) 2006-01-23
UY28151A1 (en) 2004-07-30
HK1088317A1 (en) 2006-11-03

Similar Documents

Publication Publication Date Title
DK1578740T3 (en) 1,2,4-triaminobenzene derivatives suitable for the treatment of central nervous system disorders
BG106586A (en) Pyrazolopyramidines as therapeutic agents
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
JO2372B1 (en) Prodrugs of 4-phenyl-pyridine derivatives
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
MXPA05009359A (en) 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators.
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
CA2534549A1 (en) Pteridine derivatives for the treatment of septic shock and tnf-.alpha.-related diseases.
HK1080456A1 (en) N-substituted hydromorphones and the use thereof
MY124786A (en) Bis-arylsulfones
MXPA05010000A (en) Substituted p-diaminobenzene derivatives.
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU7538200A (en) Sapogenin derivatives and their use in the treatment of cognitive dysfunction
IN2005KO00312A (en)
WO2002018379A3 (en) 7-oxo pyridopyrimidines
DE50211929D1 (en) Pyrimidinderivate
BG105962A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
DE69917005D1 (en) SUBSTITUTED PYRROLOBENZIMIDAZOLE DERIVATIVES FOR ANTI-INFLAMMATION
SI1362590T1 (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
MY139844A (en) 1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system
BG108164A (en) Glyt-1 inhibitors
DK1196176T3 (en) Use of beta-naphthoquinone derivatives for the preparation of drugs having an inhibitory effect on the brain's release of glutamate